Cribstone Capital Management, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cribstone Capital Management, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q4 2022$3,447
+14.9%
380.0%0.00%0.0%
Q3 2022$3,0000.0%380.0%0.00%0.0%
Q2 2022$3,000
+50.0%
38
+46.2%
0.00%
+100.0%
Q1 2022$2,0000.0%26
+4.0%
0.00%0.0%
Q4 2021$2,0000.0%250.0%0.00%0.0%
Q3 2021$2,0000.0%250.0%0.00%0.0%
Q2 2021$2,0000.0%250.0%0.00%0.0%
Q1 2021$2,0000.0%250.0%0.00%0.0%
Q4 2020$2,0000.0%250.0%0.00%
-50.0%
Q3 2020$2,0000.0%250.0%0.00%0.0%
Q2 2020$2,0000.0%250.0%0.00%0.0%
Q1 2020$2,0000.0%250.0%0.00%0.0%
Q4 2019$2,000
-93.3%
25
-92.8%
0.00%
-88.9%
Q3 2019$30,000
-40.0%
348
-36.5%
0.02%
-33.3%
Q2 2019$50,000
-20.6%
548
-16.0%
0.03%
-18.2%
Q1 2019$63,000
-31.5%
652
-39.2%
0.03%
-29.8%
Q4 2018$92,0000.0%1,0720.0%0.05%
+11.9%
Q3 2018$92,000
+13.6%
1,0720.0%0.04%
+5.0%
Q2 2018$81,000
-27.0%
1,072
-22.1%
0.04%
-27.3%
Q1 2018$111,000
+12.1%
1,377
+17.0%
0.06%
+17.0%
Q4 2017$99,000
+25.3%
1,177
+27.1%
0.05%
+14.6%
Q3 2017$79,000
-14.1%
926
-16.0%
0.04%
-18.0%
Q2 2017$92,000
-4.2%
1,102
-15.2%
0.05%
-3.8%
Q1 2017$96,000
+84.6%
1,299
+77.5%
0.05%
+62.5%
Q4 2016$52,000
-7.1%
7320.0%0.03%
-5.9%
Q3 2016$56,000
-6.7%
7320.0%0.03%
-8.1%
Q2 2016$60,0007320.04%
Other shareholders
NOVARTIS A G shareholders Q1 2023
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders